ACTIVATO Achieves AAHRPP Accreditation
On September 24, 2025, the Association for the Accreditation of Human Research Protection Programs (AAHRPP) announced that ACTIVATO, located in Sendai, Miyagi, Japan, has received full accreditation. This development makes ACTIVATO the third organization in Japan to adhere to AAHRPP's rigorous standards for research ethics and protections.
ACTIVATO operates as a nonprofit independent institutional review board (IRB), providing oversight for research conducted at seven university hospitals in the Tohoku region. These include significant institutions such as Hirosaki University School of Medicine, Akita University School of Medicine, and Tohoku University Hospital, among others. By conducting ethical reviews, ACTIVATO assures that clinical trials—both domestically and abroad—maintain high ethical standards and safeguard participant rights.
Elyse Summers, President and CEO of AAHRPP, emphasized the importance of such accreditation in today’s global research environment. She noted that with over 600 accredited entities worldwide, the standards established by AAHRPP are pivotal in ensuring the safety of research participants and promoting high-quality, ethical research practices.
Impact of Accreditation
To attain accreditation, organizations must demonstrate the incorporation of extensive safeguards across all levels of their research operations. This includes a commitment to high standards for research practices and a dedication to continuous improvement. In a research landscape that is increasingly collaborative, being accredited provides organizations with added assurance and a competitive edge.
In conjunction with ACTIVATO, AAHRPP also announced the reaccreditation of several prominent organizations across the United States, such as the Dana-Farber Cancer Institute and the University of Minnesota. This highlights the ongoing commitment of medical and research institutions to uphold ethical standards in their research efforts.
AAHRPP’s accreditation extends beyond the U.S., with entities accredited in nations including Australia, Belgium, Brazil, and several countries in Asia. This global reach underlines the universal need for ethical oversight in research and the evolving nature of collaborative studies that often cross national borders.
Future Aspirations
As ACTIVATO begins this new chapter of accredited status, it is poised to influence clinical ethics in Japan significantly. By further solidifying its role as a key player in ethical research review, ACTIVATO not only enhances its credibility but also improves the trust placed in the research conducted within and outside Japan.
The road ahead for ACTIVATO is promising as it continues to uphold the integrity of research in a field that is constantly innovating and expanding. The accreditation by AAHRPP serves as a powerful affirmation of its dedication to ethical research practices and participant protection.
For more information about AAHRPP and its accredited organizations, you can visit
AAHRPP's official website.